Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic ratsSamar A. Antar, Ayman M. Mahmoud, Amira E. Farage et al.|Life Sciences|2021Cited by 70